PND54 - A LONG TERM ANALYSIS OF THE CLINICAL AND COST EFFECTIVENESS OF GLATIRAMER ACETATE USING FINAL 10-YEAR RESULTS FROM THE UK MULTIPLE SCLEROSIS RISK SHARING SCHEME

Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.2020
https://www.valueinhealthjournal.com/article/S1098-3015(18)35322-1/fulltext
Title : PND54 - A LONG TERM ANALYSIS OF THE CLINICAL AND COST EFFECTIVENESS OF GLATIRAMER ACETATE USING FINAL 10-YEAR RESULTS FROM THE UK MULTIPLE SCLEROSIS RISK SHARING SCHEME
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)35322-1&doi=10.1016/j.jval.2018.09.2020
First page :
Section Title :
Open access? : No
Section Order : 1373
Categories :
Tags :
Regions :
ViH Article Tags :